Advisory Services Network’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Advisory Services Network’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,788	Closed	-$87.2K	–	2497
2023 Q4	$87.2K	Buy	+3,788	New	+$76.1K	﹤0.01%	1726
2023 Q2	–	Sell	-5,400	Closed	-$126K	–	2470
2023 Q1	$126K	Buy	5,400 +3,567	+195%	+$89.2K	﹤0.01%	1530
2022 Q4	$46.1K	Buy	+1,833	New	+$49.2K	﹤0.01%	2011
2021 Q4	–	Sell	-7,485	Closed	-$380K	–	1449
2021 Q3	$380K	Buy	7,485 +1,563	+26%	+$81.5K	0.01%	987
2021 Q2	$308K	Buy	5,922 +6	+0.1%	+$282	0.01%	1080
2021 Q1	$270K	Buy	5,916 +465	+9%	+$22.7K	0.01%	1076
2020 Q4	$250K	Buy	5,451 +291	+6%	+$12.6K	0.01%	980
2020 Q3	$201K	Buy	+5,160	New	+$198K	0.01%	969

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Advisory Services Network's IDNA Position: Q1 2024 in Review

Advisory Services Network sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2024, closing a stake of 3,788 shares — an estimated $87.2K sold.

Advisory Services Network first reported a position in IDNA in Q3 2020 and held it in 8 quarters. The position peaked at $380K in Q3 2021. 63 funds tracked by Wall St. Rank hold IDNA as of Q1 2024.

Advisory Services Network reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 3,788 iShares Genomics Immunology and Healthcare ETF shares in Q1 2024, an estimated $87.2K.
Advisory Services Network first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and held it in 8 quarters.
Advisory Services Network's iShares Genomics Immunology and Healthcare ETF position peaked at $380K in Q3 2021.
63 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.